ArticleDrug design, development and therapy2020

The Antagonist of Retinoic Acid Receptor α, ER-50891 Antagonizes the Inhibitive Effect of All-Trans Retinoic Acid and Rescues Bone Morphogenetic Protein 2-Induced Osteoblastogenic Differentiation.

Siqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.